Angiotensin IV (Human) (0.5 mg vial)

R.L. Haberl, P.J. Decker, and K.M. Einhäupl, Circ. Res., 68, 1621 (1991). (Biological Activitiy)

J.W. Harding, V.I. Cook, A.V. Miller-Wing, J.M. Hanesworth, M.F. Sardinia, K.L. Hall, J.W. Stobb, G.N. Swanson, J.K.M. Coleman, J.W. Wright, and E.C. Harding, Brain Res., 583, 340 (1992). (Specific in Brain)

J.M. Hanesworth, M.F. Sardinia, L.T. Krebs, K.L. Hall, and J.W. Harding, J. Pharmacol. Exp. Ther., 266, 1036 (1993). (Specific in Heart)

M. de Gasparo, A. Husain, W. Alexander, K.J. Catt, A.T. Chiu, M. Drew, T. Goodfriend, J.W. Harding, T. Inagami, and P.B.M.W.M. Timmermanns, Hypertension, 25, 924 (1995). (AT4 Receptor; Non AT1/2 Recognition, Nomenclature)

I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology, Vol. 37, Springer-Verlag, Berlin, 1974. (Review) 

M.J. Peach, Physiol. Rev., 57, 313 (1997). (Review)